Key result
This review describes the history, current guidelines, diagnostic methods, treatment options, and promising new developments in the understanding and management of hypertrophic cardiomyopathy.
This review summarizes the historical context, current diagnostic and management guidelines, and future directions for hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy with a prevalence of 1 in 500 in the general population. Since the first pathological case series at post mortem in 1957, we have come a long way in its understanding, diagnosis and management. Here, we will describe the history of our understanding of HCM including the initial disease findings, diagnostic methods and treatment options. We will review the current guidelines for the diagnosis and management of HCM, current gaps in the evidence base and discuss the new and promising developments in this field.
No takes yet. Share an insight, caveat, or question.
Liew et al. (2017) conducted a review in Hypertrophic cardiomyopathy (HCM). This review describes the history, current guidelines, diagnostic methods, treatment options, and promising new developments in the understanding and management of hypertrophic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: